THE IMPORTANCE OF TOTAL PROSTHESIS IN PATIENTS WITH

Öz

Dentists are at risk in terms of pain, because of The elderly population continues to increase in the world, especially in developed and developing countries. Today, noninfectious diseases are becoming the leading cause of injuries and deaths. In the next decade, the people who now direct the health and social policies will be confronted with major problems due to systemic diseases rapidly increasing with age. Systemic diseases and their oral manifestations are important. This review provides information on systemic diseases that have significance in prosthodontics and points to be considered while making dentures in individuals with these diseases

Anahtar Kelimeler

• Systemic diseases, dentures, points to be considered

TOTAL PROTEZ OLGULARINDA SİSTEMİK HASTALIKLARIN ÖNEMİ

Öz

Yaşlı nüfus dünyada, özellikle gelişen ve gelişmekte olan ülkelerde artmaya devam etmektedir. Günümüzde bulaşıcı olmayan hastalıklar, sakatlıkların ve ölümlerin başlıca sebebi olmaya başlamıştır. Gelecek on yılda sağlık ve sosyal politikayı yönlen- direnler, yaşla birlikte hızla artan sistemik hastalıklar yüzünden büyük problemlerle karşı karşıya kalacak- lardır. Sistemik hastalıklar ve ağızda görülen bulguları önemlidir. Bu derlemede protetik açıdan önem arz eden sistemik hastalıklar ve bu hastalıklara sahip bireylere protez yaparken dikkat edilecek hususlar hakkında bilgi verilmiştir.

Anahtar Kelimeler

• Sistemik hastalıklar, protez, dikkat edilecek hususlar

Kaynakça

1. Özcan B. Bruksizme eşlik eden miyofasyal ağrı sendromlu ve temporomandibular rahatsızlığı olan hastalarda oklüzal splint ve tens tedavilerinin klinik ve ağrı eşiği üzerine olan etkinliklerinin karşılaştırıl- ması (Uzmanlık Tezi). İstanbul, 2005.
2. Çalıkkocaoğlu S. Dişsiz Hastaların Protetik Tedavisi. Klasik Tam Protezler. İstanbul, 1998: p. 20-9.
3. Sonis ST, Fazio RC, Fang L. Principales and Practice of Oral Medicine. 2nd edition. WB Saunders Co; Philedelphia 1995: p. 131- 62.
4. Bell GW, Large DM, Barclay SC. Oral health care in diabetes mellitus. SADJ. 2000;55:158-65; quiz 175. Review.
5. Walsh LJ, Cleveland DB, Gumming CG. Quantitative evaluation of Langerhans cells in median rhomboid glossitis. J Oral Pathol Med
6. Carter LC. Median rhomboid glossitis: Review of a puzzling entity. Compendium 1990; 11:448-51.
7. Grushka M. Clinical features of burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1997; 63:30-6.
8. Tourne LP, Fricton JR. Burning mounth syndrome. Critical review and proposed clinical management. Oral Surg Oral Med Oral Pathol 1992:74:158-67.

9. Cibirka RM, Nelson SK, Lefebvre Ca. Burning mouth syndrome: A review of etiologies. J Prosthet Dent 1997;78:93-7.
10. Sykes LM, Sukha A. Potential risk of serious oral infections in the diabetic patient: A clinical report . J Prosthet Dent 2001;86:569-73.
11. Renner RP, Boucher LJ, Kaufman HW.Osteoporosis in postmenopausal women. J Prosthet Dent J Prosthet Dent 1984;52:581-8.
12. Loza JC, Carpio LC, Dziak R. Osteoporosis and its relationship to oral bone loss. Curr Opin Periodontol 1996;3:27-33.
13. Nordin BE. The definition and diagnosis of osteoporosis. Calcif Tissue Int 1987;40:57-8.
14. Ortman LF, Hausmann E, Dunford RG. Skeletal osteopenia and residual ridge resorption. J Prosthet Dent 1989;61:321-5.
15. von Wowern N, Kollerup G. Symptomatic osteoporosis- a risk factor for residual ridge reduction of the jaws. J Prosthet Dent 1992; 67: 656-60.
16. Wical KE, Brussee P. Effect of a calcium and vitamin D supplement on alveolar ridge resorption in immediate denture patients. J Prosthet Dent 1979:41:4-9.
17. Faine MP. Dietary habits related to preservation of oral and skeletal bone mass in women. J Prosthet Dent 1995;73:65-72.
18. Berkey DB, Berg RG, Ettinger RL, Mersel A, Mann J. The old-old dental patient: the challenge of clinical decision-making. J Am Dent Assoc 1996;127;321-2.
19. Akarırmak Ü. Osteoporoz tedavisinde bifosfonatlar ve deneysel tedaviler. İstanbul Üniv Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri Osteoporoz Sempozyumu 1999; 91-9.
20. Harorlı A, Yılmaz AB, Akgül HM. Diş Hekimliğinde Radyolojide Temel Kavramlar ve radyodiagnostik. Erzurum, Atatürk Üniv. Ofset tesisleri, 2001: p.35.
21. Cohen AS. Proteins of the systemic amyloidosis. Curr Opin Rheumatol 1994; 6: 55-67.
22. Brad WN, Douglas DD, Carl MA, Jerry EB. Oral and Maxillofacial Pathology. W.B. Saunders Co; Philedelphia 1995:p. 604-8.
23. Ünlü M, Onur Ö. Ağız hastalıklarının teşhis ve tedavisi. İstanbul, 2003: p. 47-267.
24. DeRossi SS, Raghavendra S. Anemia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95; 131-41.
25. Olivieri NF. Treatment strategies for hemoglobin E beta-thalassemia. Blood Rev 2012;26 Suppl 1:S28- 30. doi: 10.1016/S0268-960X(12)70009-7.
26. Nunes C, Escudier M, Sanderson J. Disorders of the mouth. Medicine 2007; 35: 189-93.
27. Atkinson JC, Grisius M, Massey W. Salivary hypofunction and xerostomia: diagnosis and treatment. Dent Clin North Am. 2005;49:309-26.
28. Ghezzi M. ELISA,''Systemic diseases and their treatments in the elderly:impact on oral health'',Journal of Public Health Dentistry 2000;60:290.
29. Dawes C, Edgar WM, O'Mullane DM. Factors influencing salivary flow rate and composition. In saliva and Oral Health. British Dental Association London 1996; 27-41.
30. Diaz-Arnold AM, Marek CA. The impact of saliva on patient care: A literature review. J Prosthet Dent 2002;88:337-43.
31. Özdemir AK. Hareketli Protezler (Kliniğe Hazırlık). Sivas, 2002;p. 19-25.
32. Budtz-Jorgensen E.
33. Oral mucosal lesions
34. associated with wearing of removable denture. J
35. Oral Pathol 1981;10:65-80.
36. Witzel AL, Pires Mde F, de Carli ML, Rabelo GD, Nunes TB, da Silveira FR. Candida albicans isolation from buccal mucosa of patients with HIV wearing removable dental prostheses. Int J Prosthodont. 2012;25:127-31.
37. Badrian H, Ghasemi E, Khalighinejad N, Hosseini N. The effect of three different disinfection materials on alginate impression by spray method. ISRN Dent. 2012;2012:695151. doi: 10.5402/2012/ 695151.
38. Yarom N, Barnea E, Nissan J, Gorsky M. Dental management of patients with myasthenia gravis: a literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:158-63.
39. Schneider PE. Dental management of a child with severe myasthenia gravis. Spec Care Dentist 37. Allain H, Bentué-Ferrer D, Akwa Y. Diseasemodifying drugs and Parkinson’s disease. Prog Neurobiol 2008;84:25–39.
40. Nakayama Y, Washio M, Mori M. Oral health conditions in patients with Parkinson's disease. J Epidemiol 2004;14:143-50.
41. Ship JA, Fox PC, Michalek JE, Cummins MJ, Richards AB. Treatment of primary Sjögren's syndrome with low-dose natural human interferon- alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group. J Interferon Cytokine Res 1999;19:943-51.
42. Jagger RG, Absi EG, Jeremiah HG, Sugar AW. Bilateral mandibular condylysis in a patient with systemic sclerosis. Dentomaxillo fac Radiol 2006;35:461-3.
43. Tülek N, Aydıntuğ O, Özoran K, Kınıklı G, Düzgün N, Duman M, Tokgöz G. Sklerodermanın erken klinik bulguları. Ankara Tıp Mecmuası (the journal of the faculty of medicine) 1994;47: 309-16.
44. Corrêa L, Frigerio ML, Sousa SC, Novelli MD.Oral lesions in elderly population: a biopsy survey using 2250 histopathological records. 2006;23:48- 54.
45. Dorey JL, Blasberg B, MacEntee MI, Conklin RJ. Oral mucosal disorders in denture wearers. J Prosthet Dent1985;53:210-3.
46. Altuğ HA, Şençimen M, Okçu KM. Oral liken planus: olgu sunumu. Gülhane Tıp Dergisi 2010;52:140-2